Cerebral infarction is also known as ischemic stroke, including atherosclerotic thrombotic cerebral infarction, cerebral embolism and lacunar cerebral infarction, etc. Drug therapy is still the main means of treatment for cerebral infarction, and the following drugs are commonly used in clinical practice: 1. Ultra-early thrombolytic drugs: used for patients with ultra-early cerebral infarction (within 6 hours of onset), including urokinase, recombinant tissue fibrinogen activator, etc., with a high risk of concurrent bleeding The above drugs should be applied intravenously to restore blood supply to brain tissues and save brain cells in suitable patients after evaluation by professional physicians. Anti-platelet therapy drugs: Anti-platelet therapy is a common strategy for the prevention and treatment of thrombotic disorders, and commonly used anti-platelet aggregation drugs include aspirin and clopidogrel. 3.Cerebroprotective drugs: Commonly used drugs include edaravone, cytarabine and olanzapine, which can reduce ischemic brain injury by scavenging free radicals and blocking excitatory amino acid receptors, and play a cerebroprotective role. Statins: Atorvastatin, fluvastatin and other drugs are commonly used to play the role of lipid-lowering and plaque stabilization, which can improve the prognosis of cerebral infarction patients. 5.Anticoagulant drugs: including low-molecular heparin and warfarin, etc., which are used for the treatment of patients with high level of combined blood hypercoagulability or embolic diseases such as atrial fibrillation. 6.Other drugs: such as fibrillation-lowering drugs, vasodilating drugs and some Chinese medicinal preparations, etc., which can be used according to the patient’s condition. As can be seen, there are many drugs used in the treatment of cerebral infarction, and the best treatment should be selected under the guidance of professional physician assessment to achieve the best clinical efficacy.